[1]孙小敏,高莉莉.病毒性肝硬化患者血浆输注前后凝血功能指标的变化分析[J].现代检验医学杂志,2018,33(06):149-152.[doi:10.3969/j.issn.1671-7414.2018.06.039]
　SUN Xiao-min,GAO Li-li.Analysis of Changes in Coagulation Function Indexes before and after Plasma Infusion in Patients with Viral Cirrhosis[J].Journal of Modern Laboratory Medicine,2018,33(06):149-152.[doi:10.3969/j.issn.1671-7414.2018.06.039]
点击复制

病毒性肝硬化患者血浆输注前后凝血功能指标的变化分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年06期
页码:
149-152
栏目:
检验与临床
出版日期:
2018-12-24

文章信息/Info

Title:
Analysis of Changes in Coagulation Function Indexes before and after Plasma Infusion in Patients with Viral Cirrhosis
文章编号:
1671-7414(2018)06-149-04
作者:
孙小敏1; 高莉莉2
1.延安市中心血站,陕西延安 716000; 2.延安大学附属医院输血科; 陕西延安 716000
Author(s):
SUN Xiao-min1; GAO Li-li2
1.Yan'an Center Blood Station,Shaanxi Yan'an 716000,China; 2.Department of Blood Transfusion,Affiliated Hospital of Yan'an University,Shaanxi Yan'an 716000,China
关键词:
病毒性肝硬化;  血浆输注;  凝血功能
分类号:
R575.2; R457.1
DOI:
10.3969/j.issn.1671-7414.2018.06.039
文献标志码:
A
摘要:
目的 回顾性分析病毒性肝硬化患者血浆输注前后凝血功能指标的变化情况。方法 以2014年6月～2016年6月延安大学附属医院所有诊断为病毒性肝硬化且首次输注血浆的86例住院患者病例资料为研究对象,采用凝固法检测凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)和纤维蛋白原(FIB)四项,胶乳免疫比浊法检测D-二聚体(D-Dimer,D-D)和纤维蛋白降解产物(fiber protein degradation product,FDP)。结果 病毒性肝硬化患者输注血浆后PT值显著降低,APTT延长,D-D和FDP显著增高,差异均有统计学意义(t=8.00,4.46,7.07,8.27,均P<0.05),以年龄段、性别分组均有显著性变化,差异有统计学意义(P<0.05); 病毒性肝硬化患者输注血浆前TT﹑FIB和输注血浆后相比无显著性变化(t=0.78,1.16,均P>0.05),以年龄段、性别分组均无显著性变化,差异无统计学意义(P>0.05)。结论 病毒性肝硬化患者输注血浆后凝血功能得到改善。
Abstract:
Objective To retrospectively analyze the changes of coagulation function indexes before and after plasma infusion in patientswith viral cirrhosis.Methods From June 2014 to June 2016,all the 86 inpatients who were diagnosed with viral cirrhosis and the first infusion of plasma were enrolled in the Affiliated Hospital of Yan'an University.The coagulation method was used to detect prothrombin time(PT).Activated partial thromboplastin time(APTT),thrombin time(TT),fibrinogen(FIB),latex immunoturbidimetric assay for D-dimer(DD),fibrin degradation products(Fiber protein degradation product,FDP).Results After transfusionof plasma in patients with viral cirrhosis,the PT value was significantly decreased,APTT was prolonged,and DD and FDP were significantly increased(t=8.00,4.46,7.07,8.27,all P<0.05),and were significantly grouped by age and sex.The difference of sexual change was statistically significant(P<0.05).There was no significant change in plasma TT,FIB and plasma infusion in patients with viral cirrhosis(t=0.78,1.16,P>0.05).There were no significant changes inage group and gender group(P>0.05).The difference wasnot statistically significant.Conclusion Patients withviral cirrhosis had improved blood coagulation after infusion of plasma.

参考文献/References:

[1] 刘相富,方志刚,邝丽华,等.肝硬化患者临床输血合理性分析[J].中山大学学报(医学科学版),2017,38(4):590-595.
Liu XF,Fang ZG,Kuang LH,et al.Clinical blood transfusion analysis of liver cirrhosis[J].Journal of Sun Yatsen University(Medical Sciences),2017,38(4):590-595.
[2] 朱大年,王庭槐.生理学[M].8版.北京:人民卫生出版社,2013:55-79.
Zhu DN,Wang TH.Physiology[M].8th Ed.Beijing:People's MedicalPublishing House,2013:55-79.
[3] 李亚峰,王树亚,李 平.血浆置换治疗失代偿期原发性胆汁性肝硬化1例[J].江苏医药,2018,44(4):477-478.
Li YF,Wang SY,Li P.One case of decompensated primary biliary cirrhosis treated with plasma exchange[J].Jiangsu Medical Journal,2018,44(4):477-478.
[4] 王 震,陈秉宇,杜垚强,等.肝硬化患者血浆输注临床分析[J].全科医学临床与教育,2015,13(3):248-251.
Wang Z,Chen BY,Du YQ,et al.Usage of plasma in patients with hepatic cirrhosis[J].Clinical Education of General Practice,2015,13(3):248-251.
[5] 郑玉峰,田笑笑,王瑞芳.不同Child-Pugh分级的肝硬化患者凝血四项以及胆碱酯酶检测的临床意义[J].中国医学工程,2016,24(10):4-6.
Zheng YF,Tian XX,Wang RF.Clinical significance of four coagulation indexes and cholinesterase test for patients with liver cirrhosis at differentChild-Pugh grades[J].China Medical Engineering,2016,24(10):4-6.
[6] 杨汉才,李关华.肝硬化患者凝血四项、D-二聚体水平及AT-Ⅲ的表达及临床意义[J].中国实验诊断学,2015,19(8):1366-1368.
Yang HC,Li GH.Expression changes of coagulation four indices,D-dimer and Antithrombin-III in patients with cirrhosis and its clinical significance[J].Chinese Journal of Laboratory Diagnosis,2015,19(8):1366-1368.
[7] 马妍艳.凝血四项在肝硬化诊断中的应用及价值探析[J].中国医药科学,2015,5(13):211-212,217.
Ma YY.Four items of blood coagulation in the diagnosis of liver cirrhosis and the value of application[J].China Medicine and Pharmacy,2015,5(13):211-212,217.
[8] Horie Y.Granulocytapheres and plasma exchange for severe alcoholic hepatitis[J].Journal of Gastroenterol Hepatol,2012,27(suppl2):99-103.
[9] Gaur P,Singh AK,Shukia NK,et al.Inter-relation of Th1,Th2,Th17 andTreg cytokines in oral cancer patients and their clinical significance[J].Hum Immunol,2014,75(4):330-337.
[10] 李芙蕾,余祖江.重症肝炎患者细胞因子动态变化的研究进展[J].河南医学研究,2014,23(1):136-138.
Li FL,Yu ZJ.Research progress of the cytokines changes in severe hepatitis patients[J].Henan Medical Research,2014,23(1):136-138.
[11] 吴秀继,唐爱国,邓碧兰,等.凝血四项及AT-Ⅲ,D-二聚体在肝硬化患者中的变化及临床意义[J].国际检验医学杂志,2014,35(6):755-756.
Wu XJ,Tang AG,Deng BL,et al.Changes 4 coagulation indicators and AT-III,D-dimer in patients with liver cirrhosis and their clinical significance[J].International Journal of Laboratory Medicine,2014,35(06):755-756.
[12] 黄 鹤,聂庆东,张秀梅.肝硬化患者凝血功能检测分析[J].中国肝脏病杂志(电子版),2011,3(4):32-34.
Huang H,Nie QD,Zhang XM.Analysis on effect of coagulation function detection in patients with liver cirrhosis[J].Chinese Journal of Liver Diseases(Electronic Version),2011,3(4):32-34.
[13] 王冬梅,张振宇.肝硬化患者凝血功能结果分析[J].微量元素与健康研究,2013,30(1):16-17.
Wang DM,Zhang ZY.Analysis of coagulation function in patients with cirrhosis[J].Studies of Trace Elements and Health,2013,30(1):16-17.

备注/Memo

备注/Memo:
作者简介:孙小敏(1972-),女,本科学历,医学检验专业,副主任技师,研究方向:输血检验技术,E-mail:978868621@qq.com。
通讯作者:高莉莉(1972-),女,医学检验专业,本科学历,主任技师,研究方向:输血检验技术,E-mail:245047479@qq.com。
更新日期/Last Update: 2018-11-30